Stocks · News reference

Bone Biologics Announces Six Australian Hospital Sites Under Agreement For First-In-Human NB1 Spinal Fusion Pilot Trial, Doubling Participating Centers; Expects To Complete Enrollment By Year-End 2026

Sep 8, 2026, 12:32 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 26, 2026, 9:07 PMBenzinga Insights
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2 earnings came
ALPS BBLG CELU HSCS INTS
BenzingaAug 12, 2026, 5:02 PMBenzinga Newsdesk
Bone Biologics shares are trading lower. The company announced that the validated shelf life of its rhNELL-1 protein has been extended to 32 months.
BBLG
BenzingaAug 12, 2026, 12:03 PMBenzinga Newsdesk
Bone Biologics Announces Validated Shelf Life Of rhNELL-1 Protein Extended To 32 Months, Up From 29 Months In May
BBLG